Prognositic value of suppressed markers of bone turnover (BTO) after 6 months of androgen deprivation therapy (ADT) in prostate cancer.

4594 Background: Elevated markers of bone turnover at baseline are prognostic for poorer cancer outcomes. Suppressed levels on therapy may be prognostic for better ADT efficacy in controlling prost...